NCT06457230

Brief Summary

To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired medial prefrontal cortex (mPFC) -cerebellar pulses on methamphetamine use in patients and to develop a novel physiotherapeutic intervention to optimise the treatment and management of addicted patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Dec 2024Aug 2026

First Submitted

Initial submission to the registry

June 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

December 24, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

June 10, 2024

Last Update Submit

December 11, 2025

Conditions

Keywords

Repetitive transcranial magnetic stimulationCerebellumFrontopolar cortexMethamphetamineCortico-Cortical Paired Associative Stimulation

Outcome Measures

Primary Outcomes (1)

  • cognitive flexibility

    Based on tasks and scales assessing cognitive flexibility, including: 1.Probabilistic reversal learning task (The matching of symbols and pictures was reversed without informing the subjects and their cognitive flexibility in the reversed condition was assessed); 2.Volatile reversal learning task (participants were presented with two stimuli associated with their potential feedback magnitude. They were instructed to choose one of the two stimuli to receive feedback, but only one stimulus would result in feedback. ); 3.The Wisconsin Card Sorting Test (WCST) (a classic neuropsychological task where participants match response cards to four key cards based on hidden sorting rules (color, shape, or number). They receive "right" or "wrong" feedback after each match and must deduce the current rule, which changes without warning after several consecutive correct matches.); 4. The Cognitive Flexibility Inventory (CFI) scale is a 20-item self-report measure.

    Probabilistic reversal learning task: baseline, post-intervention, and at a follow-up session one weeks later; Volatile reversal learning task and Wisconsin Card Sorting Test: baseline and post-intervention; The CFI scale: baseline.

Secondary Outcomes (7)

  • Craving

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • Electroencephalographic (EEG) Electrophysiological Results

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • response inhibition

    SST task: baseline, post-intervention, and at a follow-up session one weeks later; BIS-11 scale: baseline.

  • Depression

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • Anxiety

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • +2 more secondary outcomes

Study Arms (2)

Sham Cerebellar Stimulation + Sham mPFC Stimulation Group

SHAM COMPARATOR

This is the sham stimulation group. The coil will be placed vertically over the cerebellar and mPFC brain regions, allowing participants to perceive the coil's vibration and sound without receiving effective intervention. All other stimulation parameters are identical to those in the active intervention group.

Device: Sham Intervention Group

Cerebellar-mPFC Dual-Coil Paired-Pulse TMS Intervention Group

EXPERIMENTAL

The stimulation protocol involved delivering a pulse to the cerebellum first, followed by a pulse to the mPFC after a 6ms inter-stimulus interval (ISI). This 6ms interval was determined based on findings from our prior mechanistic study.

Device: Paired Associative Stimulation Targeting the Cerebellar-mPFC

Interventions

The protocol consisted of 180 pulse trains. Each train contained 5 pulse pairs delivered over 1 second, resulting in a stimulation frequency of 5 Hz. Within each pulse pair, the cerebellum was stimulated first, followed by the mPFC after a 6-ms inter-stimulus interval (ISI). In total, 900 pulse pairs were administered, and a complete intervention session lasted 11 minutes and 57 seconds.

Cerebellar-mPFC Dual-Coil Paired-Pulse TMS Intervention Group

The coil will be placed vertically over the cerebellar and mPFC brain regions, allowing participants to perceive the coil's vibration and sound without receiving effective intervention. All other stimulation parameters are identical to those in the active intervention group.

Sham Cerebellar Stimulation + Sham mPFC Stimulation Group

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Primary substance of abuse is methamphetamine.
  • Meets the DSM-5 diagnostic criteria for severe methamphetamine use disorder (≥6 symptoms present within the past year).
  • Age: 18-60 years.
  • Education level of primary school or above, with the ability to comprehend questionnaires and behavioral tasks.
  • Normal vision and hearing; right-handed.
  • No prior participation in any TMS-related intervention therapy.

You may not qualify if:

  • Presence of any metallic implants (e.g., dental prostheses, orthodontic braces, bone fixation plates, aneurysm clips, intrauterine devices) or implanted medical devices such as cardiac pacemakers or neurostimulators.
  • Chronic or severe somatic diseases (e.g., cardiac conditions, uncontrolled hypertension, physical disabilities).
  • Comorbid psychiatric disorders (e.g., schizophrenia, depressive disorders, anxiety disorders).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Min Zhao, PhD

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

Study Officials

  • Min Zhao, PhD

    Shanghai Mental Health Center

    STUDY CHAIR

Central Study Contacts

Min Zhao, PhD

CONTACT

64387250 Zhao, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 13, 2024

Study Start

December 24, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after de-identification, will be made available at the discretion of the corresponding author, following a formal request and execution of a data use agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations